콜레라 백신 시장 규모, 점유율, 성장 분석 : 제품 유형별, 투여 경로별, 최종사용자별, 연령층별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)
Cholera Vaccines Market Size, Share, and Growth Analysis, By Type, By Product, By Route of Administration, By End User, By Age Group, By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드:1662999
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 02월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 콜레라 백신 시장 규모는 2023년에 8,020만 달러로 평가되며, 2024년 8,670만 달러에서 2032년에는 1억 6,166만 달러로 성장하며, 예측 기간 중(2025-2032년) CAGR 8.1%로 성장할 전망입니다.
콜레라는 오염된 음식이나 물을 통해 감염되는 심각한 세균성 전염병으로, 심한 설사, 탈수 및 기타 쇠약 증상을 특징으로 하는 세계 보건에 심각한 위협이 되고 있습니다. 콜레라균은 수 시간에서 수일 내에 발병하며, 조속히 치료하지 않으면 사망에 달할 수 있습니다. 콜레라 발생의 주요 원인으로는 불결한 위생, 불충분한 위생 환경, 깨끗한 식수에 대한 접근성 부족 등을 들 수 있습니다. 다행히 백신 접종이 중요한 해결책이 될 수 있으며, 소수의 살아있는 콜레라균에 감염시켜 면역력을 높일 수 있습니다. 정맥, 근육, 경구 등 다양한 방법으로 시행되는 백신 접종은 세계보건기구(WHO)와 같은 기관에서 권장하는 공중보건 전략에서 중요한 역할을 하며, 이 감염병을 퇴치하는 데 도움을 주고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
콜레라 백신 시장 규모 : 유형별
시장 개요
전세포 콜레라 백신(Whole Cell V. Cholerae O1 with Recombinant B- subunit)
살균 경구 백신(Killed Oral O1 and O139)
콜레라 백신 시장 규모 : 제품별
시장 개요
Vaxchora
Dukoral
Shanchol
기타 제품
콜레라 백신 시장 규모 : 투여 경로별
시장 개요
주사제 백신
경구 백신
콜레라 백신 시장 규모 : 최종사용자별
시장 개요
병원
홈케어
전문 클리닉
기타
콜레라 백신 시장 규모 : 연령층별
시장 개요
성인
어린이
콜레라 백신 시장 규모 : 유통 채널별
시장 개요
병원 약국
온라인 약국
소매 약국
콜레라 백신 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Valneva SE(France)
Sanofi(France)
Emergent BioSolutions(USA)
EuBiologics(South Korea)
Shantha Biotechnics(India)
Hilleman Laboratories(Singapore)
Astellas Pharma(Japan)
Incepta Vaccine(Bangladesh)
Vabiotech(France)
Bharat Biotech(India)
Biological E.(India)
Serum Institute of India(India)
Panum Institute(Denmark)
Walter Reed Army Institute of Research(USA)
National Institutes of Health(NIH)(USA)
World Health Organization(WHO)(Switzerland)
Centers for Disease Control and Prevention(CDC)(USA)
Medecins Sans Frontieres(MSF)(Switzerland)
PATH(USA)
결론과 제안
KSA
영문 목차
영문목차
Global Cholera Vaccines Market size was valued at USD 80.2 million in 2023 and is poised to grow from USD 86.7 million in 2024 to USD 161.66 million by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).
Cholera, a serious bacterial infection transmitted through contaminated food and water, poses a significant global health threat marked by severe diarrhea, dehydration, and other debilitating symptoms. The Vibrio cholera bacterium causes this illness, which can manifest within hours to days, and can be fatal if not treated promptly. Key contributors to cholera outbreaks include poor hygiene, inadequate sanitation, and lack of access to clean drinking water. Fortunately, vaccination offers a vital solution, promoting immunity by exposing individuals to a small number of live cholera bacteria. Administered through various methods including intravenous, intramuscular, or oral routes, cholera vaccines are instrumental in combating this infectious disease, playing a crucial role in public health strategies endorsed by organizations like the World Health Organization.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cholera Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cholera Vaccines Market Segments Analysis
Global Cholera Vaccines Market is segmented by Type, Product, Route of Administration, End User, Age Group, Distribution Channel and region. Based on Type, the market is segmented into Whole Cell V. Cholerae O1 with Recombinant B- subunit and Killed Oral O1 and O139. Based on Product, the market is segmented into Vaxchora, Dukoral, Shanchol and Other Products. Based on Route of Administration, the market is segmented into Injectables Vaccines and Oral Vaccines. Based on End User, the market is segmented into Hospitals, Homecare, Specialty Clinics and Others. Based on Age Group, the market is segmented into Adults and Children. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Online Pharmacy and Retail Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Cholera Vaccines Market
The growth of the global cholera vaccines market is primarily driven by innovative approaches in developing new vaccines, heightened awareness surrounding cholera prevention, and the prevalence of unhealthy lifestyle choices, such as inadequate sanitation and consumption of contaminated food. Furthermore, intensified government initiatives and vaccination campaigns have bolstered market expansion. However, the market may face challenges due to stringent FDA regulations and an extended approval timeline for new pharmaceutical products, which can impede the introduction of potentially effective cholera vaccines. Overall, the interplay of these factors shapes the dynamic landscape of the cholera vaccines market on a global scale.
Restraints in the Global Cholera Vaccines Market
One of the major factors hindering the growth of the global cholera vaccines market is the prolonged time required for vaccine development, coupled with the stringent regulatory approval processes in place. These challenges can create delays in bringing new vaccines to market, which may ultimately impact the availability of effective cholera prevention methods. As a result, these factors can constrain the overall expansion and accessibility of cholera vaccines, especially in regions where the disease is prevalent. Consequently, addressing these hurdles is crucial for enhancing the market's growth trajectory and improving public health outcomes related to cholera.
Market Trends of the Global Cholera Vaccines Market
The global cholera vaccines market is experiencing a significant upward trend, propelled by the alarming rise in cholera cases linked to inadequate sanitation and hygiene, particularly in rural and remote regions. As cholera outbreaks become more prevalent, public health initiatives and governmental support are heightening awareness about the critical role of vaccination in combatting this preventable disease. The increasing focus on disease prevention, coupled with advancements in vaccine technology and distribution strategies, is further driving demand. Moreover, collaborative efforts between organizations and health authorities to enhance accessibility underpin a promising growth trajectory for the cholera vaccines market in the coming years.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Cholera Vaccines Market Size by Type & CAGR (2025-2032)
Market Overview
Whole Cell V. Cholerae O1 with Recombinant B- subunit
Killed Oral O1 and O139
Global Cholera Vaccines Market Size by Product & CAGR (2025-2032)
Market Overview
Vaxchora
Dukoral
Shanchol
Other Products
Global Cholera Vaccines Market Size by Route of Administration & CAGR (2025-2032)
Market Overview
Injectables Vaccines
Oral Vaccines
Global Cholera Vaccines Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals
Homecare
Specialty Clinics
Others
Global Cholera Vaccines Market Size by Age Group & CAGR (2025-2032)
Market Overview
Adults
Children
Global Cholera Vaccines Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Global Cholera Vaccines Market Size & CAGR (2025-2032)
North America (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
US
Canada
Europe (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
Brazil
Rest of Latin America
Middle East & Africa (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Valneva SE (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Sanofi (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Emergent BioSolutions (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
EuBiologics (South Korea)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Shantha Biotechnics (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Hilleman Laboratories (Singapore)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Astellas Pharma (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Incepta Vaccine (Bangladesh)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Vabiotech (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Bharat Biotech (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Biological E. (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Serum Institute of India (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Panum Institute (Denmark)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Walter Reed Army Institute of Research (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
National Institutes of Health (NIH) (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
World Health Organization (WHO) (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Centers for Disease Control and Prevention (CDC) (USA)
